Friday, November 6, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleNasdaq· July 28, 2026

Stocks Mixed on Earnings Results and Weakness in Chipmakers

View original at nasdaq.com
Stocks Mixed on Earnings Results and Weakness in Chipmakers The S&P 500 Index ($SPX) (SPY) today is up +0.05%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.738%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -1.12%…
Opening lines of the source · Nasdaq · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Claimed to have struck facilities linked to Saudi Aramco in the Red Sea port towns of Jizan and Yanbu on Saturday

    60% confidence
  • Q2 earnings may increase by +23%, close to Q1's blowout earnings of +30%, which was more than double the +12% analysts had expected

    60% confidence
  • Forecasting Q3 net sales of $1.95 billion to $2.05 billion, weaker than the consensus of $2.11 billion

    60% confidence
  • Raised the possibility of intensified action against Iran

    60% confidence
  • Reported Q2 net sales of $10.40 billion, above the consensus of $10.03 billion

    60% confidence
  • Raising its full-year comparable EPS forecast to up +9% to +10% from a previous view of +8% to +9%

    60% confidence
  • Boosting full-year revenue forecast to $17.28 billion to $17.48 billion from a previous forecast of $17.15 billion to $17.35 billion, stronger than consensus of $17.28 billion

    60% confidence
  • Cutting full-year adjusted EBITDA estimate to $850 million to $925 million from a previous forecast of $940 million to $1.02 billion, below consensus of $970.3 million

    60% confidence
  • Downgraded RXO to sell from hold with a price target of $19

    60% confidence
  • Upgraded Intuitive Surgical to buy from hold with a price target of $500

    60% confidence
  • Forecasting Q3 core sales of $4.9 billion to $5.0 billion, the midpoint below the consensus of $5.0 billion

    60% confidence
  • Reported adjusted EPS of $3.70, better than the consensus of $3.51, and raised full-year adjusted EPS forecast to $11.80 to $12.20

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com
Stocks Mixed on Earnings Results and Weakness in Chipmakers — Source | Via News | Via News